Literature DB >> 11592035

Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus.

S K Nath1, J A Kelly, B Namjou, T Lam, G R Bruner, R H Scofield, C E Aston, J B Harley.   

Abstract

Both systemic lupus erythematosus (SLE) and vitiligo are autoimmune disorders that have strong evidence of complex genetic contributions to their etiology, but, to date, efforts using genetic linkage to find the susceptibility genes for either phenotype have met with limited success. Since autoimmune diseases are thought to share at least some of their genetic origins, and since only a small minority (16 of 92) of the European-American pedigrees multiplex for SLE in our collection have one or more affected members with vitiligo, we hypothesized that these pedigrees might be more genetically homogeneous at loci important to both SLE and vitiligo and, hence, have increased power for detection of linkage. We therefore evaluated genomewide microsatellite-marker-scan data for markers at an average marker density of approximately 11 cM in these 16 European-American pedigrees and identified a significant linkage at 17p13, where the maximum multipoint parametric LOD score was 3.64 (P<4.3x10(-5)) and the nonparametric linkage score was 4.02 (P<2.8x10(-5)), respectively. The segregation behavior of this linkage suggests a recessive mode of inheritance with a virtually homogeneous genetic effect in these 16 pedigrees. These results support the hypotheses that SLE and vitiligo may share important genetic effects and that sampling on the basis of clinical covariates dramatically improves power to identify genetic effects.

Entities:  

Mesh:

Year:  2001        PMID: 11592035      PMCID: PMC1235552          DOI: 10.1086/324470

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus.

Authors:  V Magnusson; A K Lindqvist; C Castillejo-López; H Kristjánsdottir; K Steinsson; G Gröndal; G Sturfelt; L Truedsson; E Svenungsson; I Lundberg; I Gunnarsson; A I Bolstad; H J Haga; R Jonsson; L Klareskog; J Alcocer-Varela; D Alarcón-Segovia; J D Terwilliger; U B Gyllensten; M E Alarcón-Riquelme
Journal:  Genomics       Date:  2000-12-15       Impact factor: 5.736

2.  Parametric and nonparametric linkage analysis: a unified multipoint approach.

Authors:  L Kruglyak; M J Daly; M P Reeve-Daly; E S Lander
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  Hypopigmentation, vitiligo, and melanoma. New data, more enigmas.

Authors:  J J Nordlund
Journal:  Arch Dermatol       Date:  1987-08

4.  Report of the Committee on Methods of Linkage Analysis and Reporting.

Authors:  P M Conneally; J H Edwards; K K Kidd; J M Lalouel; N E Morton; J Ott; R White
Journal:  Cytogenet Cell Genet       Date:  1985

5.  Studies on vitiligo. I. Epidemiological profile in Calcutta, India.

Authors:  S K Das; P P Majumder; R Chakraborty; T K Majumdar; B Haldar
Journal:  Genet Epidemiol       Date:  1985       Impact factor: 2.135

6.  Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analyses of 187 sib-pair families.

Authors:  P M Gaffney; W A Ortmann; S A Selby; K B Shark; T C Ockenden; K E Rohlf; N L Walgrave; W P Boyum; M L Malmgren; M E Miller; G M Kearns; R P Messner; R A King; S S Rich; T W Behrens
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

7.  Genome scan of human systemic lupus erythematosus by regression modeling: evidence of linkage and epistasis at 4p16-15.2.

Authors:  C Gray-McGuire; K L Moser; P M Gaffney; J Kelly; H Yu; J M Olson; C M Jedrey; K B Jacobs; R P Kimberly; B R Neas; S S Rich; T W Behrens; J B Harley
Journal:  Am J Hum Genet       Date:  2000-11-09       Impact factor: 11.025

8.  IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes.

Authors:  Y L Li; C L Yu; H S Yu
Journal:  J Invest Dermatol       Date:  2000-12       Impact factor: 8.551

9.  A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families.

Authors:  P M Gaffney; G M Kearns; K B Shark; W A Ortmann; S A Selby; M L Malmgren; K E Rohlf; T C Ockenden; R P Messner; R A King; S S Rich; T W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  Pattern of familial aggregation of vitiligo.

Authors:  P P Majumder; J J Nordlund; S K Nath
Journal:  Arch Dermatol       Date:  1993-08
View more
  29 in total

1.  Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis.

Authors:  Richard A Spritz; Katherine Gowan; Dorothy C Bennett; Pamela R Fain
Journal:  Am J Hum Genet       Date:  2004-01       Impact factor: 11.025

Review 2.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

Authors:  Richard A Spritz
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

3.  A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families.

Authors:  Jian-Jun Chen; Wei Huang; Jin-Ping Gui; Sen Yang; Fu-Sheng Zhou; Quan-Geng Xiong; Hong-Bo Wu; Yong Cui; Min Gao; Wei Li; Jin-Xian Li; Kai-Lin Yan; Wen-Tao Yuan; Shi-Jie Xu; Jian-Jun Liu; Xue-Jun Zhang
Journal:  Am J Hum Genet       Date:  2005-04-04       Impact factor: 11.025

Review 4.  Genetics of Vitiligo.

Authors:  Richard A Spritz; Genevieve H L Andersen
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

5.  Association study between the TP53 Rs1042522G/C polymorphism and susceptibility to systemic lupus erythematosus in a Chinese Han population.

Authors:  Jie Yang; Ji-Min Zhu; Song Wu; Jing Li; Ming-Rui Wang; Ting-Ting Wang; Yu-Wei Lu
Journal:  Rheumatol Int       Date:  2017-02-09       Impact factor: 2.631

6.  Update on the genetics characterization of vitiligo.

Authors:  Hani A Al-Shobaili
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

7.  Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.

Authors:  Cheng Quan; Yun-Qing Ren; Lei-Hong Xiang; Liang-Dan Sun; Ai-E Xu; Xing-Hua Gao; Hong-Duo Chen; Xiong-Ming Pu; Ri-Na Wu; Chao-Zhao Liang; Jia-Bin Li; Tian-Wen Gao; Jian-Zhong Zhang; Xiu-Li Wang; Jun Wang; Rong-Ya Yang; Ling Liang; Jian-Bin Yu; Xian-Bo Zuo; Sheng-Quan Zhang; Shu-Mei Zhang; Gang Chen; Xiao-Dong Zheng; Pan Li; Jun Zhu; Yong-Wei Li; Xiao-Dong Wei; Wei-Song Hong; Ying Ye; Yong Zhang; Wei-Su Wu; Hui Cheng; Pu-Ling Dong; Da-Yan Hu; Yang Li; Min Li; Xin Zhang; Hua-Yang Tang; Xian-Fa Tang; Sheng-Xin Xu; Su-Min He; Yong-Mei Lv; Min Shen; Hong-Quan Jiang; Ying Wang; Kai Li; Xiao-Jing Kang; Yu-Qin Liu; Li Sun; Zhi-Fang Liu; Shao-Qiong Xie; Cheng-Yao Zhu; Qiang Xu; Jin-Ping Gao; Wen-Long Hu; Cheng Ni; Ting-Meng Pan; Yun Li; Sha Yao; Cai-Feng He; Yang-Sheng Liu; Ze-Ying Yu; Xian-Yong Yin; Feng-Yu Zhang; Sen Yang; Youwen Zhou; Xue-Jun Zhang
Journal:  Nat Genet       Date:  2010-06-06       Impact factor: 38.330

8.  Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults.

Authors:  K B Onel; D Huo; D Hastings; J Fryer-Biggs; M K Crow; K Onel
Journal:  Lupus       Date:  2009-01       Impact factor: 2.911

Review 9.  Current advances in the human lupus genetics.

Authors:  Nan Shen; Betty P Tsao
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

10.  Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.

Authors:  Yunqing Ren; Sen Yang; Shengxin Xu; Min Gao; Wei Huang; Tianwen Gao; Qiaoyun Fang; Cheng Quan; Chi Zhang; Liangdan Sun; Yanhua Liang; Jianwen Han; Zhimin Wang; Fengyu Zhang; Youwen Zhou; Jianjun Liu; Xuejun Zhang
Journal:  PLoS Genet       Date:  2009-06-19       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.